IASOglio 2 GBq/ml, solution for injection bottle, 15 ml
Active ingredients: O-(2-fluorethyl)-L-thyrosine
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injectionbottle, 15 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- IASOglio 2 GBq/mL, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 15 ml
- Marketing authorisation holder
- CURIUM AUSTRIA (AUTRICHE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 27 Jun 2023
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64499306CIP75501051CIP133400955010517Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FLUOROÉTHYL-L TYROSINE (18F)solution | 2 GBq à la date et à l'heure de calibration · 1 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.